Preliminary Study of Pancreatic Cancer Associated with Helicobacter pylori Infection

Cell Biochemistry and Biophysics

Volumn 71, Issue 1, 2015, Pages 397-400

  Ai, Fulu ^a   Hua, Xiangdong ^a   Liu, Yefu ^a   Lin, Jie ^a   Feng, Zhaoqiang ^a  

^a LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Helicobacter infection; Pancreatic cancer; Relevance

Indexed keywords

HELICOBACTER; HELICOBACTER PYLORI;

BACTERIUM ANTIBODY;

ADULT; AGED; COMPLICATION; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PANCREAS TUMOR; PHYSIOLOGY; RISK FACTOR;

ADULT; AGED; ANTIBODIES, BACTERIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84920800458     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-0211-2     Document Type: Article

References (23)

1. Xu, P., Huang, Q., Liu, C. H., et al. (2011). Risk factors for pancreatic cancer: A case–control study. Tumor,31(7), 653–657.
2. Dou, Y. C., & Wang, J. B. (2008). Detection of H. pylori infection in patients with pancreatic cancer and clinical significance. Journal of Jilin University (Medicine Edition),34(2), 317–319.
3. Hidalgo, M. (2010). Pancreatic cancer. New England Journal of Medicine,362, 1605–1617.
4. Hassan, M. M., Bondy, M. L., Wolff, R. A., Abbruzzese, J. L., Vauthey, J. N., et al. (2007). Risk factors for pancreatic cancer: Case–control study. American Journal of Gastroenterology,102, 2696–2707.
5. Lowenfels, A. B., & Maisonneuve, P. (2002). Epidemiologic and etiologic factors of pancreatic cancer. Hematology/Oncology Clinics of North America,16, 1–16.
6. Kang, R., & Tang, D. (2012). Autophagy in pancreatic cancer pathogenesis and treatment. American Journal of Cancer Research,2, 383–396.
7. Raimondi, S., Maisonneuve, P., & Lowenfels, A. B. (2009). Epidemiology of pancreatic cancer: An overview. Nature Reviews Gastroenterology and Hepatology,6, 699–708.
8. Wu, C., Miao, X., Huang, L., Che, X., Jiang, G., et al. (2012). Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nature Genetics,44, 62–66.
9. Zhang, X., Zhong, R., Zhang, Z., Yuan, J., Liu, L., et al. (2011). Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. Molecular Carcinogenesis,50, 876–883.
10. Trikudanathan, G., Philip, A., Dasanu, C. A., & Baker, W. L. (2011). Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP,12(1), 26–31.
11. Raderer, M., Wrba, F., Kornek, G., Maca, T., Koller, D. Y., Weinlaender, G., et al. (1998). Association between Helicobacter pylori infection and pancreatic cancer. Oncology,55, 16–19.
12. Stolzenberg-Solomon, R. Z., Blaser, M. J., Limburg, P. J., Perez-Perez, G., Taylor, P. R., Virtamo, J., et al. (2001). Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. Journal of the National Cancer Institute,93, 937–941.
13. Lindkvist, B., Johansen, D., Borgström, A., & Manjer, J. (2008). A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer,8, 321.
14. de Martel, C., Llosa, A. E., Friedman, G. D., Vogelman, J. H., Orentreich, N., Stolzenberg-Solomon, R. Z., et al. (2008). Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prevention,17, 1188–1194.
15. Risch, H. A., Yu, H., Lu, L., & Kidd, M. S. (2010). ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: A case–control study. Journal of the National Cancer Institute,102, 502–505.
16. Wadstrom, T., Fryzek, J. P., Demirjian, S., Choi, J. W., Garabrant, D. H., Nyren, O., et al. (2004). Antibodies to Helicobacter bills in patients with pancreatic carcinoma. Helicobacter,9, 538.
17. Jesnowski, R., Isaksson, B., Möhrcke, C., Bertsch, C., Bulajic, M., Schneider-Brachert, W., et al. (2010). Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology,4, 462–466.
18. Nakayama, M., Iwakiri, R., Hara, M., Ootani, H., Shimoda, R., Tsunada, S., et al. (2009). Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. Journal of Gastroenterology,44(9), 912–918.
19. Wang, G. Y., Huang, X. H., & Wu, G. P. (2009). Influence of Helicobacter pylori infection on serum IL-6, IL-8 and NO in duodenal ulcer patients. Journal of Hainan Medical College,15(8), 45–47.
20. Tang, J. H., & Lv, N. H. (2008). A study on the relationship of Helicobacter pylori and vitamin C to gastric mucosa lesions. Chinese Journal of Postgraduates of Medicine,31(10), 23–25.
21. Shimizu, S., Nakamura, S., Kishino, M., Konishi, H., & Shiratori, K. (2009). Role of antithrombotic therapy and nonsteroidal anti-inflammatory drug use in bleeding gastroduodenal ulcers. Internal Medicine,48(9), 631–637.
22. Lee, S. W., Chang, C. S., Lee, T. Y., Yeh, H. Z., Tung, C. F., & Peng, Y. C. (2010). Risk factors and therapeutic response in Chinese patients with peptic ulcer disease. World Journal of Gastroenterology,16(16), 2017–2022.
23. Sokic-Milutinovic, A., Krstic, M., Rozer-Smolovic, B., & Alempijevic, T. (2010). Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy: 4 Months follow-up study. Digestive Diseases and Sciences,55(10), 2887–2892.